CN102671128B - Drug for treating arteriosclerosis - Google Patents
Drug for treating arteriosclerosis Download PDFInfo
- Publication number
- CN102671128B CN102671128B CN2012101543203A CN201210154320A CN102671128B CN 102671128 B CN102671128 B CN 102671128B CN 2012101543203 A CN2012101543203 A CN 2012101543203A CN 201210154320 A CN201210154320 A CN 201210154320A CN 102671128 B CN102671128 B CN 102671128B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- parts
- radix
- fructus
- curcumae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 229940079593 drug Drugs 0.000 title claims abstract description 13
- 206010003210 Arteriosclerosis Diseases 0.000 title abstract description 13
- 208000011775 arteriosclerosis disease Diseases 0.000 title abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 26
- 239000004863 Frankincense Substances 0.000 claims abstract description 13
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 3
- 241000255791 Bombyx Species 0.000 claims description 14
- 241000717739 Boswellia sacra Species 0.000 claims description 14
- 241000756943 Codonopsis Species 0.000 claims description 14
- 241000237903 Hirudo Species 0.000 claims description 14
- 241000283956 Manis Species 0.000 claims description 14
- 241001057584 Myrrha Species 0.000 claims description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000411851 herbal medicine Species 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000006200 vaporizer Substances 0.000 claims description 3
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- 244000164439 Curcuma angustifolia Species 0.000 claims description 2
- 241001523579 Ostrea Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 208000002173 dizziness Diseases 0.000 abstract description 9
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 206010008479 Chest Pain Diseases 0.000 abstract description 2
- 206010020772 Hypertension Diseases 0.000 abstract description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 2
- 210000004556 brain Anatomy 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 2
- 206010022437 insomnia Diseases 0.000 abstract description 2
- 230000004793 poor memory Effects 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 206010008590 Choking sensation Diseases 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 206010022562 Intermittent claudication Diseases 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 240000003915 Lophatherum gracile Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241001282397 Manis pentadactyla Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 206010028372 Muscular weakness Diseases 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 206010033557 Palpitations Diseases 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 206010047513 Vision blurred Diseases 0.000 abstract 1
- 208000024980 claudication Diseases 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 230000000391 smoking effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000011084 recovery Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a drug for treating arteriosclerosis, which is prepared by the following traditional Chinese medicines of: white peony, hawthorn, cherokee rose fruit, Codonopsis pilosula, lophatherum gracile, rhizoma atractylodis, silkworm larva, Polygonum cuspidatum, semen cassia, rhizoma alismatis, radix bupleuri, radix curcumae, fruit of Chinese wolfberry, Poria cocos, plantain seed, white atractylodes rhizome, Manis pentadactyla, gastrodia elata, Ligusticum wallichii, trigone, zedoary, leech, Polygonum multiflorum, frankincense, myrrh and oyster. The drug provided by the invention has better treatment effects on the common symptoms of the patients with arteriosclerosis, such as palpitation, flustering, chest pain, choking sensation in chest, headache, dizziness, cold and numb extremities, soreness and weakness of limbs, claudication, blurred vision, poor memory, insomnia and dreaminess, and also has better preventive effect on the city dwellers, the person who engages in intense brain works, the obese person, the heavy smoking person, the patient with hypertension, the patient with diabetes mellitus, the patient with hyperlipemia and the population susceptible to the arteriosclerosis; and the drug has the outstanding effects of no toxic or side effects, no untoward effect, and high cure rate.
Description
1, technical field
The present invention relates to a kind of Chinese medicine preparation, specifically a kind ofly treat arteriosclerotic medicine.
2, background technology
Arteriosclerosis is a kind of non-inflammation pathological changes of tremulous pulse, can make that ductus arteriosus wall thickens, hardening, follows the string, official jargon is narrow and small.Arteriosclerosis is with age and the angiopathy that occurs, and its rule normally occurs at adolescence, increases the weight of period, falls ill to person in middle and old age.Now Therapeutic Method comparatively commonly used is the therapy of oral drugs, has a medical expense high, has the problem of side effect.
This disease has the characteristics such as large to human health damage, that sickness rate is high, the course of disease is long, to patient, has brought great misery, and existing medicine can only alleviate patient's misery and remove patient's clinical manifestation and can not eradicate the purpose that this disease reaches healing.
3, summary of the invention
The purpose of this invention is to provide a kind of therapeutic effect good, be free from side effects can realize treating both the principal and secondary aspects of a disease a kind ofly treat arteriosclerotic medicine.
The present invention is according to the Chinese medicine traditional theory, and selected have an activating blood circulation to dissipate blood stasis, and nourishing the liver and kidney improves the pure Chinese herbal medicine of immunologic function, can eradicate arteriosclerotic disease, realize treating both the principal and secondary aspects of a disease, and this medicine is easy to prepare, take rear instant effect, have no side effect, have no adverse reaction after taking medicine.
It is of the present invention that a kind of to treat arteriosclerotic medicine be to be made by the crude drug of following weight ratio:
Radix Paeoniae Alba 5-15 part, Fructus Crataegi 20-40 part, Fructus Rosae Laevigatae 5-15 part, Radix Codonopsis 3-8 part,
Herba Lophatheri 3-10 part, Rhizoma Atractylodis 5-12 part, Bombyx Batryticatus 3-8 part, Rhizoma Polygoni Cuspidati 5-15 part,
Semen Cassiae 10-20 part, Rhizoma Alismatis 3-8 part, Radix Bupleuri 5-15 part, Radix Curcumae 3-10 part,
Fructus Lycii 10-20 part, Poria 5-12 part, Semen Plantaginis 8-15 part, Rhizoma Atractylodis Macrocephalae 3-10 part,
Squama Manis 3-8 part, Rhizoma Gastrodiae 5-15 part, Rhizoma Chuanxiong 3-10 part, Rhizoma Sparganii 3-5 part,
Rhizoma Curcumae 3-5 part, Hirudo 5-8 part, Radix Polygoni Multiflori 5-15 part, Olibanum 3-10 part,
Myrrha 5-15 part, Concha Ostreae 3-8 part;
Preparation process is as follows:
Take in proportion Radix Paeoniae Alba, Fructus Crataegi, Fructus Rosae Laevigatae, Radix Codonopsis, Herba Lophatheri, Rhizoma Atractylodis, Bombyx Batryticatus, Rhizoma Polygoni Cuspidati, Semen Cassiae, Rhizoma Alismatis, Radix Bupleuri, Radix Curcumae, Fructus Lycii, Poria, Semen Plantaginis, the Rhizoma Atractylodis Macrocephalae, Squama Manis, Rhizoma Gastrodiae, Rhizoma Chuanxiong, Rhizoma Sparganii, Rhizoma Curcumae, Hirudo, Radix Polygoni Multiflori, Olibanum, each herbal medicine of Myrrha and Concha Ostreae, remove respectively impurity, dry parching to brown, by medicament mixed, the clear water that adds four times of amount medicines soaks 3 hours, in the immigration marmite, big fire is to boiling, then slow fire boiling is 3 hours, leach medicinal liquid, the clear water that adds again the qdx medicine continues to decoct 2 hours, getting supernatant send vaporizer the concentrated extractum of making, extractum is sent in drying baker and is dried at 130 ℃ of temperature, be ground into 300 order smalls, after sterilization, by the 0.5g/ grain, incapsulate, be finished product.
Also can make the said oral liquid of pharmaceutics by pharmaceutical technologies such as traditional coarse crushing, immersion, heating extraction.
It is of the present invention that a kind of to treat arteriosclerotic medicine be to be made by the crude drug of following weight ratio:
Radix Paeoniae Alba 8-12 part, Fructus Crataegi 25-35 part, Fructus Rosae Laevigatae 8-12 part, Radix Codonopsis 4-6 part,
Herba Lophatheri 5-8 part, Rhizoma Atractylodis 8-10 part, Bombyx Batryticatus 4-6 part, Rhizoma Polygoni Cuspidati 8-12 part,
Semen Cassiae 12-18 part, Rhizoma Alismatis 4-6 part, Radix Bupleuri 8-12 part, Radix Curcumae 5-8 part,
Fructus Lycii 12-18 part, Poria 6-10 part, Semen Plantaginis 10-14 part, Rhizoma Atractylodis Macrocephalae 5-8 part,
Squama Manis 4-6 part, Rhizoma Gastrodiae 8-12 part, Rhizoma Chuanxiong 5-8 part, Rhizoma Sparganii 3.5-4.5 part,
Rhizoma Curcumae 3.5-4.5 part, Hirudo 5-7 part, Radix Polygoni Multiflori 8-12 part, Olibanum 5-8 part,
Myrrha 8-12 part, Concha Ostreae 4-6 part.
It is of the present invention that a kind of to treat arteriosclerotic medicine be to be made by the crude drug of following weight ratio:
10 parts of Radix Paeoniae Alba, 30 parts of Fructus Crataegis, 10 parts of Fructus Rosae Laevigatae, 5 parts of Radix Codonopsis,
6 parts of Herba Lophatheris, 9 parts of Rhizoma Atractylodis, 5 parts of Bombyx Batryticatus, 10 parts of Rhizoma Polygoni Cuspidati,
15 parts of Semen Cassiaes, 5 parts of Rhizoma Alismatis, 10 parts of Radix Bupleuri, 6 parts of Radix Curcumaes,
15 parts of Fructus Lycii, 8 parts, Poria, 12 parts of Semen Plantaginiss, 6 parts of the Rhizoma Atractylodis Macrocephalaes,
5 parts of Squama Maniss, 10 parts, Rhizoma Gastrodiae, 6 parts of Rhizoma Chuanxiongs, 4 parts of Rhizoma Sparganii,
4 parts of Rhizoma Curcumae, 6 parts of Hirudos, 10 parts of Radix Polygoni Multiflori, 6 parts of Olibanums,
10 parts of Myrrhas, 5 parts of Concha Ostreaes.
The common sympton that the present invention occurs the arteriosclerosis patient is as listless and aching as cardiopalmus, nervous, chest pain, uncomfortable in chest, headache, dizziness, the cool fiber crops of extremity, extremity, limping, vision reduction, hypomnesis, insomnia, dreaminess etc. have good therapeutic effect, for the urbanite, be engaged in nervous brain worker, obesity, have a liking for cigarette, hypertension, diabetes, hyperlipemia is suffered from and easily suffer from this sick crowd that good preventive effect is also arranged, the outstanding effect of this medicine is to have no side effect, have no adverse reaction, radical cure efficiency is high.
The specific embodiment
Embodiment 1
Radix Paeoniae Alba 5g, Fructus Crataegi 20g, Fructus Rosae Laevigatae 5g, Radix Codonopsis 3g,
Herba Lophatheri 3g, Rhizoma Atractylodis 5g, Bombyx Batryticatus 3g, Rhizoma Polygoni Cuspidati 5g,
Semen Cassiae 10g, Rhizoma Alismatis 3g, Radix Bupleuri 5g, Radix Curcumae 3g,
Fructus Lycii 10g, Poria 5g, Semen Plantaginis 8g, Rhizoma Atractylodis Macrocephalae 3g,
Squama Manis 3g, Rhizoma Gastrodiae 5g, Rhizoma Chuanxiong 3g, Rhizoma Sparganii 3g,
Rhizoma Curcumae 3g, Hirudo 5g, Radix Polygoni Multiflori 5g, Olibanum 3g,
Myrrha 5g, Concha Ostreae 3g;
Preparation process is as follows:
Take in proportion Radix Paeoniae Alba, Fructus Crataegi, Fructus Rosae Laevigatae, Radix Codonopsis, Herba Lophatheri, Rhizoma Atractylodis, Bombyx Batryticatus, Rhizoma Polygoni Cuspidati, Semen Cassiae, Rhizoma Alismatis, Radix Bupleuri, Radix Curcumae, Fructus Lycii, Poria, Semen Plantaginis, the Rhizoma Atractylodis Macrocephalae, Squama Manis, Rhizoma Gastrodiae, Rhizoma Chuanxiong, Rhizoma Sparganii, Rhizoma Curcumae, Hirudo, Radix Polygoni Multiflori, Olibanum, each herbal medicine of Myrrha and Concha Ostreae, remove respectively impurity, dry parching to brown, by medicament mixed, the clear water that adds four times of amount medicines soaks 3 hours, in the immigration marmite, big fire is to boiling, then slow fire boiling is 3 hours, leach medicinal liquid, the clear water that adds again the qdx medicine continues to decoct 2 hours, getting supernatant send vaporizer the concentrated extractum of making, extractum is sent in drying baker and is dried at 130 ℃ of temperature, be ground into 300 order smalls, after sterilization, by the 0.5g/ grain, incapsulate, be finished product.
Embodiment 2
Radix Paeoniae Alba 15g, Fructus Crataegi 40g, Fructus Rosae Laevigatae 15g, Radix Codonopsis 8g,
Herba Lophatheri 10g, Rhizoma Atractylodis 12g, Bombyx Batryticatus 8g, Rhizoma Polygoni Cuspidati 15g,
Semen Cassiae 20g, Rhizoma Alismatis 8g, Radix Bupleuri 15g, Radix Curcumae 10g,
Fructus Lycii 20g, Poria 12g, Semen Plantaginis 15g, Rhizoma Atractylodis Macrocephalae 10g,
Squama Manis 8g, Rhizoma Gastrodiae 15g, Rhizoma Chuanxiong 10g, Rhizoma Sparganii 5g,
Rhizoma Curcumae 5g, Hirudo 8g, Radix Polygoni Multiflori 15g, Olibanum 10g,
Myrrha 15g, Concha Ostreae 8g.
Preparation process is identical with embodiment 1.
Embodiment 3
Radix Paeoniae Alba 8g, Fructus Crataegi 25g, Fructus Rosae Laevigatae 8g, Radix Codonopsis 4g,
Herba Lophatheri 5g, Rhizoma Atractylodis 8g, Bombyx Batryticatus 4g, Rhizoma Polygoni Cuspidati 8g,
Semen Cassiae 12g, Rhizoma Alismatis 4g, Radix Bupleuri 8g, Radix Curcumae 5g,
Fructus Lycii 12g, Poria 6g, Semen Plantaginis 10g, Rhizoma Atractylodis Macrocephalae 5g,
Squama Manis 4g, Rhizoma Gastrodiae 8g, Rhizoma Chuanxiong 5g, Rhizoma Sparganii 3.5g,
Rhizoma Curcumae 3.5g, Hirudo 5g, Radix Polygoni Multiflori 8g, Olibanum 5g,
Myrrha 8g, Concha Ostreae 4g.
Preparation process is identical with embodiment 1.
Embodiment 4
Radix Paeoniae Alba 12g, Fructus Crataegi 35g, Fructus Rosae Laevigatae 12g, Radix Codonopsis 6g,
Herba Lophatheri 8g, Rhizoma Atractylodis 10g, Bombyx Batryticatus 6g, Rhizoma Polygoni Cuspidati 12g,
Semen Cassiae 18g, Rhizoma Alismatis 6g, Radix Bupleuri 12g, Radix Curcumae 8g,
Fructus Lycii 18g, Poria 10g, Semen Plantaginis 14g, Rhizoma Atractylodis Macrocephalae 8g,
Squama Manis 6g, Rhizoma Gastrodiae 12g, Rhizoma Chuanxiong 8g, Rhizoma Sparganii 4.5g,
Rhizoma Curcumae 4.5g, Hirudo 7g, Radix Polygoni Multiflori 12g, Olibanum 8g,
Myrrha 12g, Concha Ostreae 6g.
Preparation process is identical with embodiment 1.
Embodiment 5
Radix Paeoniae Alba 10g, Fructus Crataegi 30g, Fructus Rosae Laevigatae 10g, Radix Codonopsis 5g,
Herba Lophatheri 6g, Rhizoma Atractylodis 9g, Bombyx Batryticatus 5g, Rhizoma Polygoni Cuspidati 10g,
Semen Cassiae 15g, Rhizoma Alismatis 5g, Radix Bupleuri 10g, Radix Curcumae 6g,
Fructus Lycii 15g, Poria 8g, Semen Plantaginis 12g, Rhizoma Atractylodis Macrocephalae 6g,
Squama Manis 5g, Rhizoma Gastrodiae 10g, Rhizoma Chuanxiong 6g, Rhizoma Sparganii 4g,
Rhizoma Curcumae 4g, Hirudo 6g, Radix Polygoni Multiflori 10g, Olibanum 6g,
Myrrha 10g, Concha Ostreae 5g.
Preparation process is identical with embodiment 1.
Model case: in the 100 routine patients through curing with this prescription, male 65 examples wherein, female's 35 examples are the course of disease the shortest half a year, the longest 10 years.
Efficacy determination: adopt 4 grade standards
Recovery from illness clinical improvements rate >=95%
Produce effects clinical improvements rate<95%,
Effective clinical improvement rate<60%,
Invalid clinical improvements rate<20%
Therapeutic effect statistics in Table
It is 88% that the present invention treats arteriosclerotic Drug therapy cure rate, and effectively cure rate is 97%.
The typical clinical case:
Case 1, Zhang, man 70 years old, be diagnosed as arteriosclerosis in city hospital, show as dizzy dizzy headache, memory obviously goes down, take multiple Chinese medicine and western medicine effect all not obvious, took this medicine before 2 years, every day twice, take dizzy headache shape after three weeks and alleviate, continue to take all symptoms after two weeks and substantially disappear, immunity also strengthens to some extent.
Case 2, field so-and-so, female 62 years old, clinical manifestation is that two sufficient pain can not be walked, can only lie up and can not get up at ordinary times, be diagnosed as arteriosclerosis, take upon somebody's introduction this medicine, take twice of this medicine every day, taken continuously after three weeks and can descend bed motion once in a while under others assisting in, it is many that whole body is also comfortable, after continuing to have taken three weeks, can oneself leave the bed and simply move, whole body also energetically, the symptom recovery from illness, patient and family members thereof are very satisfied.
Case 3, Lin, female 67 years old, clinical manifestation is hand tremor, hands acroanesthesia, easy tired, hypomnesis, by hospital diagnosis, be arteriosclerosis, take this medicine every day twice, the phenomenon of having taken continuously numbness of hand hand tremor after two weeks takes a turn for the better to some extent, continue to take two weeks afterwards clinical manifestation completely without, the disease recovery from illness, immunity also strengthens to some extent.
Case 4, Lee, man 62 years old, clinical manifestation is, dizziness, accidental angina pectoris, whole body discomfort is the several years, red tongue, tongue is few, stringy and thready pulse, be diagnosed as arteriosclerosis through hospital, renal arteriosclerosis, take this medicine twice on the one, dizzy after two weeks, anginal frequency reduces to some extent, and whole body sense of discomfort alleviates to some extent, continue to take this medicine after three weeks, clinical symptoms is completely without the recovery from illness of, the state of an illness.
Case 5, king so-and-so, man 70 years old, the health paralysis, inactive, be diagnosed as arteriosclerosis through hospital, taking twice, two week on the one rear health of this medicine slightly has consciousness, can do simple motion after adding three weeks under others' treatment, continue to take this medicine after six weeks, the control that the state of an illness is basic, I am satisfied.
Case 6, the side certain, man 45 years old, clinical presentation is, the degradation performance is obviously descended in dizzy, dizzy, poor memory, thinking, through hospital, is diagnosed as arteriosclerosis, takes upon somebody's introduction twice of this medicine every day, sx↓ after two weeks, continue to take recovery from illness after two weeks, so far not recurrence.
Claims (3)
1. treat arteriosclerotic medicine for one kind, it is characterized in that being made by the crude drug of following weight proportion:
Radix Paeoniae Alba 5-15 part, Fructus Crataegi 20-40 part, Fructus Rosae Laevigatae 5-15 part, Radix Codonopsis 3-8 part,
Herba Lophatheri 3-10 part, Rhizoma Atractylodis 5-12 part, Bombyx Batryticatus 3-8 part, Rhizoma Polygoni Cuspidati 5-15 part,
Semen Cassiae 10-20 part, Rhizoma Alismatis 3-8 part, Radix Bupleuri 5-15 part, Radix Curcumae 3-10 part,
Fructus Lycii 10-20 part, Poria 5-12 part, Semen Plantaginis 8-15 part, Rhizoma Atractylodis Macrocephalae 3-10 part,
Squama Manis 3-8 part, Rhizoma Gastrodiae 5-15 part, Rhizoma Chuanxiong 3-10 part, Rhizoma Sparganii 3-5 part,
Rhizoma Curcumae 3-5 part, Hirudo 5-8 part, Radix Polygoni Multiflori 5-15 part, Olibanum 3-10 part,
Myrrha 5-15 part, Concha Ostreae 3-8 part;
Preparation process is as follows:
Take in proportion Radix Paeoniae Alba, Fructus Crataegi, Fructus Rosae Laevigatae, Radix Codonopsis, Herba Lophatheri, Rhizoma Atractylodis, Bombyx Batryticatus, Rhizoma Polygoni Cuspidati, Semen Cassiae, Rhizoma Alismatis, Radix Bupleuri, Radix Curcumae, Fructus Lycii, Poria, Semen Plantaginis, the Rhizoma Atractylodis Macrocephalae, Squama Manis, Rhizoma Gastrodiae, Rhizoma Chuanxiong, Rhizoma Sparganii, Rhizoma Curcumae, Hirudo, Radix Polygoni Multiflori, Olibanum, each herbal medicine of Myrrha and Concha Ostreae, remove respectively impurity, dry parching to brown, by medicament mixed, the clear water that adds four times of amount medicines soaks 3 hours, in the immigration marmite, big fire is to boiling, then slow fire boiling is 3 hours, leach medicinal liquid, the clear water that adds again the qdx medicine continues to decoct 2 hours, getting supernatant send vaporizer the concentrated extractum of making, extractum is sent in drying baker and is dried at 130 ℃ of temperature, be ground into 300 order smalls, after sterilization, by the 0.5g/ grain, incapsulate, be finished product.
2. a kind of arteriosclerotic medicine for the treatment of according to claim 1 is characterized in that being made by the crude drug of following weight proportion:
Radix Paeoniae Alba 8-12 part, Fructus Crataegi 25-35 part, Fructus Rosae Laevigatae 8-12 part, Radix Codonopsis 4-6 part,
Herba Lophatheri 5-8 part, Rhizoma Atractylodis 8-10 part, Bombyx Batryticatus 4-6 part, Rhizoma Polygoni Cuspidati 8-12 part,
Semen Cassiae 12-18 part, Rhizoma Alismatis 4-6 part, Radix Bupleuri 8-12 part, Radix Curcumae 5-8 part,
Fructus Lycii 12-18 part, Poria 6-10 part, Semen Plantaginis 10-14 part, Rhizoma Atractylodis Macrocephalae 5-8 part,
Squama Manis 4-6 part, Rhizoma Gastrodiae 8-12 part, Rhizoma Chuanxiong 5-8 part, Rhizoma Sparganii 3.5-4.5 part,
Rhizoma Curcumae 3.5-4.5 part, Hirudo 5-7 part, Radix Polygoni Multiflori 8-12 part, Olibanum 5-8 part,
Myrrha 8-12 part, Concha Ostreae 4-6 part.
3. a kind of arteriosclerotic medicine for the treatment of according to claim 1 is characterized in that being made by the crude drug of following weight proportion:
10 parts of Radix Paeoniae Alba, 30 parts of Fructus Crataegis, 10 parts of Fructus Rosae Laevigatae, 5 parts of Radix Codonopsis,
6 parts of Herba Lophatheris, 9 parts of Rhizoma Atractylodis, 5 parts of Bombyx Batryticatus, 10 parts of Rhizoma Polygoni Cuspidati,
15 parts of Semen Cassiaes, 5 parts of Rhizoma Alismatis, 10 parts of Radix Bupleuri, 6 parts of Radix Curcumaes,
15 parts of Fructus Lycii, 8 parts, Poria, 12 parts of Semen Plantaginiss, 6 parts of the Rhizoma Atractylodis Macrocephalaes,
5 parts of Squama Maniss, 10 parts, Rhizoma Gastrodiae, 6 parts of Rhizoma Chuanxiongs, 4 parts of Rhizoma Sparganii,
4 parts of Rhizoma Curcumae, 6 parts of Hirudos, 10 parts of Radix Polygoni Multiflori, 6 parts of Olibanums,
10 parts of Myrrhas, 5 parts of Concha Ostreaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101543203A CN102671128B (en) | 2012-05-18 | 2012-05-18 | Drug for treating arteriosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101543203A CN102671128B (en) | 2012-05-18 | 2012-05-18 | Drug for treating arteriosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102671128A CN102671128A (en) | 2012-09-19 |
| CN102671128B true CN102671128B (en) | 2013-12-25 |
Family
ID=46804112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101543203A Expired - Fee Related CN102671128B (en) | 2012-05-18 | 2012-05-18 | Drug for treating arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102671128B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103656495B (en) * | 2013-11-26 | 2016-01-06 | 张雅静 | Salvia miltiorrhiza phytic acid electuary |
| CN109876113A (en) * | 2019-03-27 | 2019-06-14 | 苏凤哲 | A kind of Chinese medicine composition and its preparation method and application for treating carotid plaques |
| CN113304235B (en) | 2020-02-26 | 2022-07-26 | 北京重生医药科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101461900A (en) * | 2007-12-17 | 2009-06-24 | 吴伶 | Pure medicinal formulation for treating arteriosclerosis |
-
2012
- 2012-05-18 CN CN2012101543203A patent/CN102671128B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101461900A (en) * | 2007-12-17 | 2009-06-24 | 吴伶 | Pure medicinal formulation for treating arteriosclerosis |
Non-Patent Citations (4)
| Title |
|---|
| 从气虚血瘀论治动脉粥样硬化潜证;孙学刚等;《中华中医药学刊》;20070810;第25卷(第08期);全文 * |
| 孙学刚等.从气虚血瘀论治动脉粥样硬化潜证.《中华中医药学刊》.2007,第25卷(第08期),全文. |
| 浅析从毒论治动脉粥样硬化;王辉等;《时珍国医国药》;20080920;第19卷(第09期);全文 * |
| 王辉等.浅析从毒论治动脉粥样硬化.《时珍国医国药》.2008,第19卷(第09期),全文. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102671128A (en) | 2012-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103990081B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice | |
| CN102671128B (en) | Drug for treating arteriosclerosis | |
| CN104173517B (en) | The Chinese medicine preparation for the treatment of primary trigeminal neuralgia and preparation method | |
| CN104784511A (en) | Medicine for treating coronary heart disease | |
| CN103386089B (en) | Chinese medicine composition for treating liver-stomach disharmony | |
| CN103816454A (en) | Pure traditional Chinese medicine capsule for treating arteriosclerosis | |
| CN104127567B (en) | A kind of Chinese medicine composition for the treatment of diabetic peripheral neuropathy | |
| CN101461900B (en) | Pure medicinal formulation for treating arteriosclerosis | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN104043031A (en) | Traditional Chinese medicine for treating depression | |
| CN102657758B (en) | Traditional Chinese medical composition and preparation method and application thereof | |
| CN105106638A (en) | Traditional Chinese medicine composition for treating heat stroke and preparation method of traditional Chinese medicine composition | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN105079515A (en) | Traditional Chinese medicine composition for treating post-traumatic headache | |
| CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
| CN104013828A (en) | Traditional Chinese medicine composition for treating head wind caused by liver-yang hyperactivity | |
| CN103860914A (en) | Chinese medicine composition for treating epilepsy | |
| CN103405660A (en) | Compound medicine for treating headache | |
| CN104127797B (en) | It is a kind of to treat Chinese medicine preparation of aphasia and preparation method thereof after craniocerebral trauma | |
| CN103495087B (en) | Traditional Chinese medicine for treating erysipelas of lower limbs | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN102579678A (en) | Medicinal composition for treating vitligo | |
| CN105749243A (en) | Traditional Chinese medicine for treating coolness diseases | |
| CN104352648A (en) | Traditional Chinese medicine preparation for treating headache due to deficiency of blood | |
| CN105327157A (en) | Traditional Chinese medicine for treating cerebrovascular blockage and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG XIA Free format text: FORMER OWNER: GE XIAOYUN Effective date: 20131118 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Xia Inventor before: Ge Xiaoyun |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250013 JINAN, SHANDONG PROVINCE TO: 252027 LIAOCHENG, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: GE XIAOYUN TO: ZHANG XIA |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20131118 Address after: 252027 Dongchangfu District Hospital of traditional Chinese medicine, 79 Station Street, Liaocheng, Shandong Applicant after: Zhang Xia Address before: 250013 Ji'nan Central Hospital, Jiefang Road 105, Shandong, Ji'nan, China Applicant before: Ge Xiaoyun |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: CAI YAN Free format text: FORMER OWNER: ZHANG XIA Effective date: 20140924 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 252027 LIAOCHENG, SHANDONG PROVINCE TO: 226143 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140924 Address after: The 22 group of Haimen town Sijia Pi Yan village 226143 Jiangsu city of Nantong Province Patentee after: Cai Yan Address before: 252027 Dongchangfu District Hospital of traditional Chinese medicine, 79 Station Street, Liaocheng, Shandong Patentee before: Zhang Xia |
|
| CB03 | Change of inventor or designer information |
Inventor after: Wang Jing Inventor after: Yu Jikui Inventor before: Zhang Xia |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171115 Address after: 276300 Yinan County People's Hospital of Linyi City, Shandong Province Co-patentee after: Yu Jikui Patentee after: Wang Jing Address before: The 22 group of Haimen town Sijia Pi Yan village 226143 Jiangsu city of Nantong Province Patentee before: Cai Yan |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131225 Termination date: 20180518 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |